Decrease in Intracellular Perforin Levels and IFN-<i>γ</i> Production in Human CD8<sup>+</sup> T Cell Line following Long-Term Exposure to Asbestos Fibers

Kumagai-Takei, Naoko; Nishimura, Yasumitsu; Matsuzaki, Hidenori; Lee, Suni; Yoshitome, Kei; Otsuki, Takemi

doi:https://doi.org/10.1155/2018/4391731

Journal of Immunology Research

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Disclosure Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2018 | Article ID 4391731 | https://doi.org/10.1155/2018/4391731

Decrease in Intracellular Perforin Levels and IFN-γ Production in Human CD8⁺ T Cell Line following Long-Term Exposure to Asbestos Fibers

Naoko Kumagai-Takei,¹Yasumitsu Nishimura,¹Hidenori Matsuzaki,^1,2Suni Lee,¹Kei Yoshitome,¹and Takemi Otsuki¹

Academic Editor: Takami Sato

Received20 Jul 2018

Revised31 Aug 2018

Accepted16 Sept 2018

Published23 Oct 2018

Abstract

Although the tumorigenicity of asbestos, which is thought to cause mesothelioma, has been clarified, its effect on antitumor immunity requires further investigation. We previously reported a decrease in the percentage of perforin⁺ cells of stimulated CD8⁺ lymphocytes derived from patients with malignant mesothelioma. Therefore, we examined the effects of long-term exposure to asbestos on CD8⁺ T cell functions by comparing long-term cultures of the human CD8⁺ T cell line EBT-8 with and without exposure to chrysotile (CH) asbestos as an in vitro model. Exposure to CH asbestos at 5 μg/ml or 30 μg/ml did not result in a decrease in intracellular granzyme B in EBT-8 cells. In contrast, the percentage of perforin⁺ cells decreased at both doses of CH exposure. CH exposure at 30 μg/ml did not suppress degranulation following stimulation with antibodies to CD3. Secreted production of IFN-γ stimulated via CD3 decreased by CH exposure at 30 μg/ml, although the percentage of IFN-γ⁺ cells induced by PMA/ionomycin did not decrease. These results indicate that long-term exposure to asbestos can potentially suppress perforin levels and the production of IFN-γ in human CD8⁺ T cells.

1. Introduction

The association between mesothelioma and asbestos exposure is undisputed [1, 2]. Previous studies have focused largely on the properties of asbestos fibers that are important in the development of MM and the mechanisms of action of asbestos in the multistage carcinogenic process [3–6]. However, it seems to be insufficient to exert all effort on studies concerning its carcinogenicity. In fact, the induction of malignant mesothelioma (MM) by exposure to asbestos is not a rapid process and takes a long period to develop [7–9]. This suggests the possibility that the development of MM might be related to other functional alterations and prompted us to suppose that exposure to inhaled asbestos might gradually impair the immune response.

On the basis of this hypothesis, we previously examined the effect of long-term exposure to asbestos on human NK and CD4⁺ T cell lines. The human NK cell line YT-A1 was cultured with continuous exposure to chrysotile (CH) asbestos at 5 μg/ml, subsequently referred to as the YT-CB5 subline. YT-CB5 showed impaired cytotoxicity and decreased cell surface expression of several NK cell-activating receptors after around 5 months from the start of the culture [10]. For an in vitro model representing continuous exposure to asbestos in a human CD4⁺ T cell line, MT-2 cells were subjected to long-term exposure to asbestos and showed a reduction in cell surface CXCR3 expression [11]. Those immune-suppressive characteristics of asbestos exposure were also demonstrated by experiments with human primary cells, in which NK cells showed low expression of activating receptor NKp46 while CD4⁺ T cells showed low CXCR3. Additionally, suppressed expression of surface NKp46 and CXCR3 was also observed in NK cells and CD4⁺ T cells derived from peripheral blood of patients with MM [10, 12].

Our interest in the immunological effects of asbestos exposure also encompasses events that occur within CD8⁺ T cells. In antitumor immunity, CD8⁺ T cells as well as NK cells play a role as effectors which kill tumor cells [13]. Following conjugation of CD8⁺ T cells with an appropriate target cell, lytic granules are transported to the point of contact with the target, and granule perforin and granzyme B are released into the immune synapse between CD8⁺ T cells and the target. Once the granule contents are released by CD8⁺ T cells, they act on the target cell to induce apoptosis [14]. The granule core is surrounded by a lipid bilayer containing lysosome-associated membrane glycoprotein CD107a, which is known to be transiently expressed on the T cell surface during degranulation [15]. Recently, we also reported that patients with MM showed lower levels of perforin in CD8⁺ lymphocytes after stimulation compared to patients with pleural plaque (PP), and the percentage of IFN-γ⁺ cells in CD8⁺ lymphocytes of patients with MM tended to be lower compared to healthy volunteers (HV) and patients with PP [16].

The findings obtained from our aforementioned studies demonstrated the asbestos-induced functional impairment of immune cells by employing experiments using long-term cultures of cell lines and short-term cultures of primary cells with asbestos exposure. However, long-term exposure of a cultured CD8⁺ T cell line to asbestos has yet to be investigated. Therefore, we hypothesized that chronic and direct exposure to asbestos might affect the antitumor immunity of CD8⁺ T cells and examined this possibility by comparing long-term cultures of the human CD8⁺ T cell line EBT-8 with and without exposure to CH asbestos as an in vitro model to analyze the effects of asbestos exposure on CD8⁺ T cells. The human CD8⁺ T cell line EBT-8 was continuously cultured with asbestos and assayed for intracellular levels of perforin, granzyme B, and IFN-γ and degranulation and production of INF-γ.

2. Materials and Methods

2.1. Cell Culture of the Human CD8⁺ T Cell Line

The human CD8⁺ T cell line EBT-8 was a gift from Prof. H. Asada [17]. EBT-8 cell line was established from large granular lymphocyte leukemia of T cell origin and shows surface expressions of CD2, CD3, CD8, HLA-DR, and T cell receptor alpha/beta, which are characteristics of cytotoxic T lymphocytes. EBT-8 was established simply by continuously culturing mononuclear cells obtained from the patient with leukemia, which means EBT-8 was not established as a specific T cell clone for a specific antigen. Cells were cultured in GIT medium (Wako Pure Chemical Industries Ltd., Osaka, Japan) supplemented with 80 U/ml recombinant human IL-2 (Takeda, Osaka, Japan), 100 μg/ml streptomycin, and 100 U/ml penicillin (Meiji Seika Pharma Co. Ltd., Tokyo, Japan). Cells were placed in 25 cm² tissue culture flasks in portrait style in a volume of 10 ml and incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air. As an in vitro model, long-term cultures of the human CD8⁺ T cell line EBT-8 with and without exposure to chrysotile asbestos were performed. The International Union Against Cancer (UICC) standard sample of chrysotile A and B asbestos was kindly provided by the Department of Occupational Health at the National Institute for Occupational Health of South Africa [18]. A Japan Association for the Study of Fiber Materials (JASFM) standard sample of chrysotile asbestos, JAWE 131, was also used since the entire UICC standard sample of chrysotile asbestos was utilized. Chrysotile fibers were separated in PBS by pipetting repeatedly and used for culture. Most of the fibers were dispersed separately in the solution but included some part of bundle or cluster of fibers. The EBT-8 cell line was continuously cultured with chrysotile asbestos at 0, 5, or 30 μg/ml for more than 1 month but less than 2 months in culture flask. Cells were regularly separated from asbestos using a Ficoll-Hypaque density gradient (Separate-L^®, Muto Pure Chemicals Co. Ltd., Tokyo, Japan) before being used for functional assays.

2.2. Cell Growth Assay

EBT-8 cells (2.5 × 10³ cells per well in 96-well flat-bottomed plates) were cultured in 100 μl of medium containing 0, 1, 5, 10, 20, 50, or 100 μg/ml of asbestos. Following 48 h of culture, the growth properties were analyzed with a water-soluble tetrazolium salt (WST-1) assay using a Premix WST-1 Cell Proliferation Assay System (Takara Bio Inc., Shiga, Japan) according to the manufacturer’s instructions. The wavelength for measuring the absorbance of the formazan product was 450 nm. The reference wavelength was 650 nm.

2.3. Assay for Expression Levels of Intracellular Molecules

To examine the expression levels of intracellular granzyme B and perforin, EBT-8-Org, EBT-8-CH5, and EBT-8-CH30 cells were fixed with 3.7% formaldehyde and then permeabilized with 0.1% Triton X-100. Fixed cells were then stained using the following antibodies (Abs): granzyme B-RPE, IgG1 negative control: RPE (both AbD Serotec, Oxford, UK), perforin-RPE, or IgG2b-RPE (both Ancell Corporation, Bayport, MN) Abs. For the staining of intracellular IFN-γ, 1.0 × 10⁵ EBT-8-Org or EBT-8-CH5 cells were stimulated with 50 ng/ml PMA and 250 ng/ml ionomycin (Sigma-Aldrich, St. Louis, MO) in GIT medium supplemented with 80 U/ml recombinant human IL-2, 100 μg/ml streptomycin, and 100 U/ml penicillin in 96-well flat-bottomed plates. GolgiStop Protein Transporter inhibitor (containing monensin) (BD Biosciences, San Jose, CA) was also added to the medium for the staining of IFN-γ. Plates were incubated at 37°C for 4 h in a humidified atmosphere of 5% CO₂. Stimulated EBT-8-Org or EBT-8-CH5 cells were harvested and stained with IFN-γ-PE Ab (BD Biosciences) using a Cytofix/Cytoperm^™ Fixation/Permeabilization kit (BD Biosciences). The percentage or mean fluorescence intensity (MFI) of cells positive for each parameter was analyzed using a FACSCalibur^™ (BD Biosciences) flow cytometer.

2.4. Detection of Degranulation

Cells were stimulated with bead-bound antibodies and assayed for degranulation. Monoclonal antibody CD3 (Beckman Coulter Inc., Brea, CA) and mouse IgG1 (BD Biosciences) were each incubated with anti-mouse IgG-coated beads (Spherotech Inc., Lake Forest, IL) at room temperature for 30 min. After washing the beads with PBS, 1.0 × 10⁴ cells were incubated with 1.0 × 10⁴ beads in GIT medium supplemented with 80 U/ml recombinant human IL-2, 100 μg/ml streptomycin, and 100 U/ml penicillin in 96-well round-bottomed plates. After the plates were incubated at 37°C for 2 h in a humidified atmosphere of 5% CO₂, cells were washed and stained with CD107a-PE Ab (BD Biosciences) before the percentage of CD107a⁺ cells was measured by flow cytometry.

2.5. Enzyme-Linked Immunosorbent Assay (ELISA)

Cells were stimulated by bead-bound antibodies in the same manner as described in Detection of Degranulation. After 48 hours of stimulation with anti-CD3-coated beads, culture supernatants of EBT-8-Org or EBT-8-J30 were collected and assayed for IFN-γ. The assay was performed using a Quantikine ELISA kit (R&D Systems Inc. Minneapolis, MN) according to the manufacturer’s instructions.

2.6. Statistical Analysis

Significant differences () were determined using analysis of variance with the post hoc test of Student-Newman-Keuls or paired Student’s -test.

3. Results

3.1. The Effect of Asbestos Exposure on Cell Growth of a Human CD8⁺ T Cell Line

To examine the effects of exposure to asbestos during a short period, the dose-dependent effects of exposure to CH asbestos on the growth of EBT-8 were assayed. The growth of EBT-8 cells was inhibited by exposure to a UICC standard sample of chrysotile asbestos at over 50 μg/ml (Figure 1(a)). The growth of EBT-8 cells was also inhibited by exposure to a JASFM standard sample of chrysotile asbestos at over 50 μg/ml (Figure 1(b)). EBT-8 cells were then cultured in the absence or presence of CH asbestos at low or middle concentrations of 5 or 30 μg/ml for more than 1 month but less than 2 months and referred to as EBT-8-Org, EBT-8-CH5, and EBT-8-CH30, respectively.

(a)

(b)

3.2. Expression Levels of Granzyme B and Perforin following Long-Term Exposure to Low-Dose Asbestos

To examine the effect of long-term exposure to low-dose asbestos on the functional properties of human CD8⁺ T cells, the expression levels of intracellular granzyme B in EBT-8-Org and EBT-8-CH5 were analyzed. As shown in Figures 2(a) and 2(b), the intracellular levels of granzyme B were very high in both EBT-8-Org and EBT-8-CH5 sublines with no significant difference in these levels between the sublines. As shown in Figures 2(c) and 2(d), the EBT-8-CH5 subline showed a statistically significant decrease in the percentage of perforin⁺ cells compared to EBT-8-Org. These results indicate that long-term exposure to CH asbestos at 5 μg/ml can potentially cause a preferential decrease in intracellular perforin levels in CD8⁺ T cells while not affecting granzyme B levels.

(a)

(b)

(c)

(d)

Figure 2

Expression levels of intracellular granzyme B and perforin following long-term exposure to low-dose asbestos. (a) Representative histograms of intracellular granzyme B in EBT-8-Org and EBT-8-CH5. An isotype control (gray) is shown in each panel. (b) Cumulative data showing the MFI of granzyme B-positive cells in EBT-8-Org or EBT-8-CH5. (c) Representative histograms of intracellular perforin in EBT-8-Org and EBT-8-CH5. An isotype control (gray) is shown in each panel. (d) Cumulative data showing the percentage of perforin-positive cells in EBT-8-Org or EBT-8-CH5. (b and d) Data represent values from 14 independent experiments. Significant differences are indicated by asterisks ().

3.3. Expression Levels of Granzyme B and Perforin following Long-Term Exposure to Middle-Dose Asbestos

To examine the effect of long-term exposure to middle-dose asbestos on the functional properties of human CD8⁺ T cells, we continuously cultured EBT-8 cells with chrysotile asbestos at 30 μg/ml in the same manner as described for the experiment utilizing low doses of asbestos. As shown in Figures 3(a) and 3(b), the expression level of granzyme B was very high in EBT-8-CH30, which was cultured at 30 μg/ml, as well as in the Org subline, with no significant difference between the sublines. The EBT-8-CH30 subline showed a decrease in the percentage of perforin⁺ cells, with a significant difference compared to EBT-8-Org (Figures 3(c) and 3(d)). These results indicate that long-term exposure to CH asbestos even at 30 μg/ml causes a preferential decrease in intracellular perforin levels in CD8⁺ T cells but does not alter the levels of granzyme B, in a similar manner to the low dose of 5 μg/ml CH.

(a)

(b)

(c)

(d)

Figure 3

Expression levels of intracellular granzyme B and perforin following long-term exposure to middle-dose asbestos. (a) Representative histograms of intracellular granzyme B in EBT-8-Org and EBT-8-CH30. An isotype control is shown in each panel. (b) Cumulative data showing the MFI of granzyme B-positive cells in EBT-8-Org or EBT-8-CH30. (c) Representative histograms of intracellular perforin in EBT-8-Org and EBT-8-CH30. An isotype control (gray) is shown in each panel. (d) Cumulative data showing the percentage of perforin-positive cells in EBT-8-Org or EBT-8-CH30. (b and d) Data represent values from 14 independent experiments. Significant differences are indicated by asterisks ().

3.4. Degranulation Induced by TCR Stimulation following Long-Term Exposure to Asbestos

Degranulation was compared between EBT-8-Org and EBT-8-CH30 since the degranulation of cytotoxic granules is a necessary step for the achievement of granzyme B/perforin-mediated cytotoxicity. To examine degranulation, the percentage of CD107a⁺ cells in stimulated cells with bead-bound IgG was subtracted from the percentage of CD107a⁺ cells in stimulated cells with bead-bound anti-CD3 Ab. EBT-8-Org and EBT-8-CH30 showed increases in cell surface expression of CD107a following stimulation with bead-bound Ab to CD3, although there was no significant difference between these sublines (Figures 4(a) and 4(b)). These results indicate that degranulation was not altered following exposure to CH asbestos, in contrast to the intragranular content of perforin.

(a)

(b)

(c)

3.5. Production of IFN-γ following Long-Term Exposure to Asbestos

CD8⁺ T cells have been shown to be crucial for the immune response against tumors through the production of effector molecules including IFN-γ as well as granzyme B and perforin [19]. In an effort to examine the expression levels of IFN-γ⁺ cells in EBT-8-Org and EBT-8-CH5, the same sublines shown in Figure 2, these sublines were stimulated with PMA/ionomycin for 4 h (Figure 5(a)). As shown in Figure 5(b), exposure to low-dose CH asbestos did not suppress the percentage of IFN-γ⁺ cells. Next, we employed stimulation with bead-bound anti-CD3 Abs to represent greater physiological stimulation and examined the effect of middle-dose asbestos on the production of IFN-γ in the supernatants harvested following 48 hours of stimulation. The production of IFN-γ in culture supernatants of EBT-8-CH30 was clearly low, with significant difference compared to EBT-8-Org (Figure 5(c)). These results indicate that long-term exposure to CH asbestos at 30 μg/ml suppresses the secretory production of IFN-γ by CD8⁺ T cells.

(a)

(b)

(c)

Figure 5

Production of IFN-γ following long-term exposure to asbestos. (a) Representative histograms of intracellular IFN-γ in EBT-8-Org or EBT-8-CH5. A nonstained control (gray) is shown in each panel. (b) Cumulative data showing the percentage of IFN-γ-positive cells in EBT-8-Org or EBT-8-CH5. Data represent values from 11 independent experiments. (c) Production of IFN-γ in culture supernatants of EBT-8-Org and EBT-8-CH30. Data represent values from 20 independent experiments. Horizontal dotted bars indicate the mean values. Significant differences are indicated by asterisks ().

4. Discussion

EBT-8-CH30 showed decreased intracellular levels of perforin and production of IFN-γ. These results indicate that in vitro exposure to asbestos for long periods can potentially impair the functions of CD8⁺ T cells. Although these findings were obtained from in vitro experiments, it is possible that lymphocytes could be exposed to asbestos in the body. Inhaled asbestos fibers migrate to the pleural cavity and are thought to translocate into lymphatics which is open on the surface of parietal pleura [20]. Furthermore, it has also been reported that asbestos fibers accumulate in the lungs as well as regional lymph nodes in people exposed to asbestos occupationally as well as nonoccupationally [21, 22]. Therefore, our present demonstration using cell lines exposed to asbestos might provide a feasible model for examining the effect of chronic asbestos exposure on cytotoxic T lymphocytes in the body. The impaired function of CD8⁺ T cells might provide an opportunity for asbestos-induced abnormal cells which temporally arise with some features of DNA damage or transformation to escape from antitumor immunity, thereby leading to the development of diseases such as MM.

Our previous study reported that CD8⁺ lymphocytes of patients with MM showed a decrease in intracellular perforin levels after stimulation and tended towards lower IFN-γ production compared to HV or patients with PP [16]. The present study examined functions of EBT-8-Org and EBT-8-CH30, and results showed that intracellular expression of perforin and production of IFN-γ were reduced in EBT-8-CH30, the subline exposed to long-term chrysotile. Thus, EBT-8-CH30 displayed several characteristics representing functional alterations, similar to that of peripheral blood CD8⁺ T cells in patients with mesothelioma. That similarity supports the idea that inhaled asbestos might chronically cause impaired function of CD8⁺ T cells and is linked to the development of MM in people exposed to asbestos. Although it cannot be denied that the characteristics of CD8⁺ T cells in patients might be influenced by immune-suppressive factors derived from the tumor, our present study clearly demonstrated that long-term exposure to asbestos specifically leads to the impairment of functions of CD8⁺ T cells. On the other hand, it remains to be clear how chronic exposure to chrysotile affected functions of CD8⁺ T cells. As chrysotile tends to have outer layer degrade in an aqueous environment for long period [23], it may be important to examine the effect of such “leached chrysotile” as well as native chrysotile fibers in the future study.

It is noteworthy that chronic exposure to chrysotile resulted in a difference in expression of perforin and granzyme B in the present study and was manifested by a decrease in the number of perforin-positive cells, unlike the case with granzyme B MFI. Perforin is expressed in cytotoxic lymphocytes including NK, CD8⁺, and CD4⁺ T (Th1) cells, but is not expressed in other cell types including B cells and nonlymphoid cells [24, 25]. Additionally, human CD8⁺ T lymphocytes in peripheral blood as well as lymphoid organs do not express perforin at the protein level and do not show cytolytic activity prior to stimulation, and perforin protein is predominantly expressed in effector CD8⁺ T cells in humans [25–27]. In contrast to perforin, granzyme B is expressed in many types of human nonlymphoid cells including plasmacytoid, dendritic cells, and IL-3-stimulated basophils [28–30]. Those findings suggest that perforin expression might be more strictly controlled and may be more crucial in contributing towards the cytotoxic role of CD8⁺ T lymphocytes compared to granzyme B, which might explain the difference in expression of perforin and granzyme B determined in our present study as mentioned above. Alternatively, the redundancy of granzyme genes may be important in considering these results. Five granzyme genes are known in humans, granzyme A, B, H, K, and M, while ten granzymes have been identified in mice [31]. As our present study only examined the expression of granzyme B, it is possible that expression of the other granzymes might be altered by chronic exposure to chrysotile asbestos. Additionally, a deficiency in one of the ten granzymes in mice led to only subtle alterations in antivirus and antitumor immunity, while a deficiency in perforin caused severe immunodeficient characteristics [31]. Those experiments perhaps underline the greater importance of perforin in CTL functions compared to granzymes and which may be reflected in the difference in perforin and granzyme expression under chronic exposure to chrysotile. There is actually a difference in the MFI of granzyme B between EBT-8-Org shown in Figures 2 and 3. This difference is probably derived from the altered function of EBT-8 cells before the start of the culture with chrysotile. We know from our own experience that EBT-8 cells show alterations in expression of perforin and granzyme B depending on the those conditions, which includes cell number in cryotubes, and the length of time cells have been stored frozen. Therefore, our present study undertook repeated examination of EBT-8 cells ( in each of Figures 2 and 3) and demonstrated significant differences between control and chrysotile-exposed cultures, as shown in Figures 2 and 3.

The secreted production of IFN-γ stimulated via CD3 decreased with CH exposure, whereas the percentage of IFN-γ⁺ cells induced by PMA/ionomycin did not decrease. We previously examined the percentage of cells positive for intracellular IFN-γ in CD8⁺ lymphocytes involved in peripheral blood mononuclear cells (PBMCs) harvested after 7 days of a mixed lymphocyte reaction (MLR) in the presence of 5 μg/ml of CH asbestos, where PMA/ionomycin was used to stimulate those harvested cells for 4 h prior to the assay for intracellular IFN-γ [32]. In that study, it was confirmed that asbestos exposure suppressed the differentiation of human mature CTLs during the MLR and was accompanied by decreases in the percentage of IFN-γ in CD8⁺ lymphocytes. Additionally, we previously confirmed a trend showing decreased percentage of cells positive for intracellular IFN-γ in CD8⁺ lymphocytes from PMA/ionomycin-stimulated PBMCs derived from patients with MM [16]. Therefore, it was our first choice to use PMA/ionomycin as a stimulator to examine the percentage of IFN-γ⁺ cells in EBT-8-CH5 and EBT-8-Org. However, there was no difference in the percentage of IFN-γ⁺ cells between EBT-8-CH5 and EBT-8-Org. Then, we used bead-bound anti-CD3 Abs, to represent greater physiological stimulation, for 48 hours and examined the effect of 30 μg/ml asbestos on the secretory production of IFN-γ. These results showed suppressed production of IFN-γ by EBT-8-CH30, the subline which suffered from long-term exposure to CH asbestos. These findings suggest that lasting exposure to asbestos might impair production of IFN-γ by influencing the machinery of T cell stimulation with CD3. On the other hand, there was no difference in the expression of CD107a, a marker for degranulation, after stimulation with CD3 between EBT-8-Org and EBT-8-CH30 sublines. This finding suggests partial, but not total, impairment of the signal transduction machinery within T cells stimulated with CD3 and may provide a valuable key in efforts to explore the mechanism of signal transduction impairment in EBT-8-CH30. Additionally, it cannot be ignored that the different results between percentage of cells positive for (Figures 5(a) and 5(b)) and secreted amount of IFN-γ (Figure 5(c)) might be attributed to the difference between EBT-8-CH5 and EBT-8-CH30. However, as both of the cell lines showed the asbestos exposure-caused effect on perforin expression, it may be more probable that the difference between Figures 5(a)–5(c) is related to the difference in pathways of stimulation.

5. Conclusion

Our present investigation is the first to show that in vitro long-term exposure to asbestos has the potential to suppress certain functions of CD8⁺ T cells. It is known that tumors cause immune-suppressive environments [33]. However, the findings obtained from the present study demonstrated that long-term exposure to asbestos impairs the performance of CD8⁺ T cells alone without any factors derived from tumors. Additionally, by using an in vitro model to analyze the effect of chronic exposure to inhaled asbestos, our present study demonstrated that low- and middle-dose asbestos exposure suppresses functions of CD8⁺ T cells. An additional study using another cell line in future might contribute to confirmation of the present results. Further investigations are needed to clarify the mechanisms involved in the suppression of CD8⁺ T cell functions upon exposure to asbestos, with the ultimate goal being to prevent the development of MM and other tumors in people who have inhaled asbestos.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon reasonable request, only if could obtain permission of the data available from Dr. Asada, because the present study was accomplished by using EBT-8, which was given kindly by him, who had originally established the cell line, under the agreement about the usage of it between each other.

Disclosure

We declare that the manuscript has been previously presented as an abstract in 32nd Triennial Congress of the International Commission on Occupational Health (ICOH) 2018; the title of which is “Effect of long-term exposure to asbestos on functional properties of human CD8+T cell line” (https://oem.bmj.com/content/oemed/75/Suppl_2/A56.3.full.pdf, https://www.researchgate.net/publication/324810039_640_Effect_of_long-term_exposure_to_asbestos_on_functional_properties_of_human_cd8t_cell_line).

Conflicts of Interest

The authors declare that they have no conflict of interest.

Acknowledgments

Grant support from JPSS KAKENHI Grants (25860470 and 16K09114) and Kawasaki Medical School Project Grant (26B39 and 29B051) is gratefully acknowledged. We thank Dr. H. Asada for generously providing the EBT-8 cells and Ms. Tamayo Hatayama and Shoko Yamamoto for their technical assistance.

References

T. A. Sporn and V. L. Roggli, “Mesothelioma,” Pathology of Asbestos-Associated Diseases, V. L. Roggli, T. D. Oury, and T. A. Sporn, Eds., Springer-Verlag, New York, NY, USA, 2004.
View at: Publisher Site | Google Scholar
B. T. Mossman, D. W. Kamp, and S. A. Weitzman, “Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers,” Cancer Investigation, vol. 14, no. 5, pp. 466–480, 1996.
View at: Publisher Site | Google Scholar
M. Stanton, M. Layard, A. Tegeris et al., “Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals,” JNCI: Journal of the National Cancer Institute, vol. 67, pp. 965–975, 1981.
View at: Publisher Site | Google Scholar
G. Guthrie Jr., “Mineral properties and their contributions to particle toxicity,” Environmental Health Perspectives, vol. 105, pp. 1003–1011, 1997.
View at: Publisher Site | Google Scholar
M. Dušinská, A. Collins, A. Kažimı́rová et al., “Genotoxic effects of asbestos in humans,” Mutation Research, vol. 553, no. 1-2, pp. 91–102, 2004.
View at: Publisher Site | Google Scholar
J. Topinka, P. Loli, P. Georgiadis et al., “Mutagenesis by asbestos in the lung of λ-lacI transgenic rats,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 553, no. 1-2, pp. 67–78, 2004.
View at: Publisher Site | Google Scholar
A. D. McDonald and J. C. McDonald, “Mesothelioma after crocidolite exposure during gas mask manufacture,” Environmental Research, vol. 17, no. 3, pp. 340–346, 1978.
View at: Publisher Site | Google Scholar
I. J. Selikoff, E. C. Hammond, and H. Seidman, “Mortality experience of insulation workers in the United States and Canada, 1943–1976,” Annals of the New York Academy of Sciences, vol. 330, pp. 91–116, 1979.
View at: Publisher Site | Google Scholar
I. J. Selikoff, E. C. Hammond, and H. Seidman, “Latency of asbestos disease among insulation workers in the United States and Canada,” Cancer, vol. 46, no. 12, pp. 2736–2740, 1980.
View at: Publisher Site | Google Scholar
Y. Nishimura, Y. Miura, M. Maeda et al., “Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 3, pp. 579–590, 2009.
View at: Publisher Site | Google Scholar
M. Maeda, Y. Nishimura, H. Hayashi et al., “Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 3, pp. 470–479, 2011.
View at: Publisher Site | Google Scholar
M. Maeda, Y. Nishimura, H. Hayashi et al., “Decreased CXCR3 expression in CD4⁺ T cells exposed to asbestos or derived from asbestos-exposed patients,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 4, pp. 795–803, 2011.
View at: Publisher Site | Google Scholar
J. Banchereau and A. K. Palucka, “Dendritic cells as therapeutic vaccines against cancer,” Nature Reviews Immunology, vol. 5, no. 4, pp. 296–306, 2005.
View at: Publisher Site | Google Scholar
M. Catalfamo and P. A. Henkart, “Perforin and the granule exocytosis cytotoxicity pathway,” Current Opinion in Immunology, vol. 15, no. 5, pp. 522–527, 2003.
View at: Publisher Site | Google Scholar
M. A. Suni, V. C. Maino, and H. T. Maecker, “Ex vivo analysis of T-cell function,” Current Opinion in Immunology, vol. 17, no. 4, pp. 434–440, 2005.
View at: Publisher Site | Google Scholar
N. Kumagai-Takei, Y. Nishimura, M. Maeda et al., “Functional properties of CD8⁺ lymphocytes in patients with pleural plaque and malignant mesothelioma,” Journal of Immunology Research, vol. 2014, Article ID 670140, 10 pages, 2014.
View at: Publisher Site | Google Scholar
H. Asada, N. Okada, K. Hashimoto et al., “Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia,” Leukemia, vol. 8, no. 8, pp. 1415–1423, 1994.
View at: Google Scholar
N. Kohyama, Y. Shinohara, and Y. Suzuki, “Mineral phases and some reexamined characteristics of the International Union Against Cancer standard asbestos samples,” American Journal of Industrial Medicine, vol. 30, no. 5, pp. 515–528, 1996.
View at: Publisher Site | Google Scholar
J. Tao, Y. Gao, M. . O. Li et al., “JNK2 negatively regulates CD8⁺ T cell effector function and anti-tumor immune response,” European Journal of Immunology, vol. 37, no. 3, pp. 818–829, 2007.
View at: Publisher Site | Google Scholar
G. Miserocchi, G. Sancini, F. Mantegazza, and G. Chiappino, “Translocation pathways for inhaled asbestos fibers,” Environmental Health, vol. 7, no. 1, p. 4, 2008.
View at: Publisher Site | Google Scholar
R. F. Dodson, M. G. Williams, C. J. Corn, A. Brollo, and C. Bianchi, “A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques,” Annals of the New York Academy of Sciences, vol. 643, pp. 53–60, 1991.
View at: Publisher Site | Google Scholar
R. F. Dodson, J. Huang, and J. R. Bruce, “Asbestos content in the lymph nodes of nonoccupationally exposed individuals,” American Journal of Industrial Medicine, vol. 37, no. 2, pp. 169–174, 2000.
View at: Publisher Site | Google Scholar
A. Morgan, “Acid leaching studies of chrysotile asbestos from mines in the Coalinga region of California and from Quebec and British Columbia,” The Annals of Occupational Hygiene, vol. 41, no. 3, pp. 249–268, 1997.
View at: Publisher Site | Google Scholar
D. Chowdhury and J. Lieberman, “Death by a thousand cuts: granzyme pathways of programmed cell death,” Annual Review of Immunology, vol. 26, no. 1, pp. 389–420, 2008.
View at: Publisher Site | Google Scholar
M. E. Pipkin, B. Ljutic, F. Cruz-Guilloty et al., “Chromosome transfer activates and delineates a locus control region for perforin,” Immunity, vol. 26, no. 1, pp. 29–41, 2007.
View at: Publisher Site | Google Scholar
D. Hamann, P. A. Baars, M. H. G. Rep et al., “Phenotypic and functional separation of memory and effector human CD8⁺ T cells,” The Journal of Experimental Medicine, vol. 186, no. 9, pp. 1407–1418, 1997.
View at: Publisher Site | Google Scholar
H. Tomiyama, T. Matsuda, and M. Takiguchi, “Differentiation of human CD8⁺ T cells from a memory to memory/effector phenotype,” Journal of Immunology, vol. 168, no. 11, pp. 5538–5550, 2002.
View at: Publisher Site | Google Scholar
M. C. M. Strik, P. J. A. de Koning, M. J. Kleijmeer et al., “Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation,” Molecular Immunology, vol. 44, no. 14, pp. 3462–3472, 2007.
View at: Publisher Site | Google Scholar
C. M. Tschopp, N. Spiegl, S. Didichenko et al., “Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma,” Blood, vol. 108, no. 7, pp. 2290–2299, 2006.
View at: Publisher Site | Google Scholar
M. C. Rissoan, T. Duhen, J. M. Bridon et al., “Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells,” Blood, vol. 100, no. 9, pp. 3295–3303, 2002.
View at: Publisher Site | Google Scholar
J. H. Russell and T. J. Ley, “Lymphocyte-mediated cytotoxicity,” Annual Review of Immunology, vol. 20, no. 1, pp. 323–370, 2002.
View at: Publisher Site | Google Scholar
N. Kumagai-Takei, Y. Nishimura, M. Maeda et al., “Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 1, pp. 28–36, 2013.
View at: Publisher Site | Google Scholar
G. P. Dunn, C. M. Koebel, and R. D. Schreiber, “Interferons, immunity and cancer immunoediting,” Nature Reviews Immunology, vol. 6, no. 11, pp. 836–848, 2006.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2018 Naoko Kumagai-Takei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1609

Downloads

771

Citations

Journal of Immunology Research

Decrease in Intracellular Perforin Levels and IFN-γ Production in Human CD8+ T Cell Line following Long-Term Exposure to Asbestos Fibers

Abstract

1. Introduction

2. Materials and Methods

2.1. Cell Culture of the Human CD8+ T Cell Line

2.2. Cell Growth Assay

2.3. Assay for Expression Levels of Intracellular Molecules

2.4. Detection of Degranulation

2.5. Enzyme-Linked Immunosorbent Assay (ELISA)

2.6. Statistical Analysis

3. Results

3.1. The Effect of Asbestos Exposure on Cell Growth of a Human CD8+ T Cell Line

3.2. Expression Levels of Granzyme B and Perforin following Long-Term Exposure to Low-Dose Asbestos

3.3. Expression Levels of Granzyme B and Perforin following Long-Term Exposure to Middle-Dose Asbestos

3.4. Degranulation Induced by TCR Stimulation following Long-Term Exposure to Asbestos

3.5. Production of IFN-γ following Long-Term Exposure to Asbestos

4. Discussion

5. Conclusion

Data Availability

Disclosure

Conflicts of Interest

Acknowledgments

References

Copyright

Decrease in Intracellular Perforin Levels and IFN-γ Production in Human CD8⁺ T Cell Line following Long-Term Exposure to Asbestos Fibers

2.1. Cell Culture of the Human CD8⁺ T Cell Line

3.1. The Effect of Asbestos Exposure on Cell Growth of a Human CD8⁺ T Cell Line